Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115952) titled 'An Observational Study of Urinary DNA Methylation Biomarkers for Monitoring Postoperative Recurrence in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)' on Jan. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Mid-to-high-risk non-muscle-invasive bladder cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-04
Target Sample Size: Postoperative Cohort of Intermediate-to-High-Risk Non-Muscle-Invasive Bladder Cancer Cases:100;
Coun...